World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
55
Citations
10828
World Ranking
12122
National Ranking
685

Lloyd R. Kelland publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Lloyd R. Kelland sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 129 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Lloyd R. Kelland D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Lloyd R. Kelland sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 55 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Lloyd R. Kelland was affiliated with University College London in the United Kingdom. Their academic career included research activities primarily based at this institution.

Available records do not list specific recent papers, frequent co-authors, or notable publication venues associated with their work. Similarly, there is no detailed information on particular fields of study, subfields, or main research topics documented.

No book publications or awards attributed to Lloyd R. Kelland have been recorded. The absence of such data suggests a limited publicly accessible bibliographic and recognition footprint.

The researcher is deceased, and all information reflects a completed academic record without ongoing contributions.

Best Publications

  • Discovery and development of anticancer aptamers.

    Christopher R. Ireson;Lloyd R. Kelland

  • Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors

    M Read;RJ Harrison;B Romagnoli;FA Tanious

  • DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90

    Lloyd R. Kelland;Swee Y. Sharp;Paul M. Rogers;Timothy G. Myers

  • Preclinical perspectives on platinum resistance.

    Lloyd R. Kelland

  • A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.

    Sharon M. Gowan;John R. Harrison;Lisa Patterson;Melanie Valenti

  • Platinum-based drugs in cancer therapy

    Lloyd R. Kelland;Nicholas P. Farrell

  • The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

    P. Mistry;L. R. Kelland;G. Abel;S. Sidhar

  • Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity.

    Stephen J. Gregson;Philip W. Howard;John A. Hartley;Natalie A. Brooks

  • The dose-rate effect in human tumour cells.

    G. Gordon Steel;Judith M. Deacon;Gillian M. Duchesne;Alan Horwich

  • 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase.

    Philip J. Perry;Martin A. Read;Rhian T. Davies;Sharon M. Gowan

  • A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity.

    John Mann;Anne Baron;Yaw Opoku-Boahen;Eric Johansson

  • Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.

    Sharon M. Gowan;Robert Heald;Malcolm F. G. Stevens;Lloyd R. Kelland

  • Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance

    Lloyd R. Kelland;Swee Y. Sharp;Ciaran F. O’Neill;Florence I. Raynaud

  • Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.

    N Farrell;L R Kelland;J D Roberts;M Van Beusichem

  • BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

    C Manzotti;G Pratesi;E Menta;R Di Domenico

  • Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.

    R John Harrison;Javier Cuesta;Gianni Chessari;Martin A Read

  • Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.

    C A Hills;L R Kelland;G Abel;J Siracky

  • Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes.

    Robert G. Buckley;Amanda M. Elsome;Simon P. Fricker;Graham R. Henderson

  • Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

    Lloyd R. Kelland;Barry A. Murrer;George Abel;Christen M. Giandomenico

  • Human telomerase inhibition by substituted acridine derivatives.

    R. John Harrison;Sharon M. Gowan;Lloyd R. Kelland;Stephen Neidle

  • Human Telomerase Inhibition by Regioisomeric Disubstituted Amidoanthracene-9,10-diones

    Philip J. Perry;Anthony P. Reszka;Alexis A. Wood;Martin A. Read

  • Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.

    S. Y. Loh;P. Mistry;L. R. Kelland;G. Abel

  • 1,4- and 2,6-Disubstituted Amidoanthracene-9,10-dione Derivatives as Inhibitors of Human Telomerase

    Philip J. Perry;Sharon M. Gowan;Anthony P. Reszka;Paolo Polucci

  • A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.

    Christopher M Incles;Christoph M Schultes;Helena Kempski;Heike Koehler

  • SJG-136 (NSC 694501), a Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity: Part 1: Cellular Pharmacology, In vitro and Initial In vivo Antitumor Activity

    John A. Hartley;Victoria J. Spanswick;Natalie Brooks;Peter H. Clingen

  • A Novel trans-Platinum Coordination Complex Possessing in Vitro and in Vivo Antitumor Activity

    Lloyd R. Kelland;Christopher F. J. Barnard;Kirste J. Mellish;Mervyn Jones

Frequent Co-Authors

Stephen Neidle
Stephen Neidle University College London
David E. Thurston
David E. Thurston King's College London
Florence I. Raynaud
Florence I. Raynaud Institute of Cancer Research
Paul Workman
Paul Workman Institute of Cancer Research
John A. Hartley
John A. Hartley University College London
Ian Judson
Ian Judson Institute of Cancer Research
Nicholas Farrell
Nicholas Farrell Virginia Commonwealth University
John R. Griffiths
John R. Griffiths University of Manchester
Richard J. Harrison
Richard J. Harrison University of Cambridge
Malcolm F. G. Stevens
Malcolm F. G. Stevens University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Chemistry, exploring related fields such as forensic science and criminal justice can open diverse career opportunities. Many students opt for online programs due to their flexibility and affordability. For example, prospective forensic professionals can find reputable online options by exploring online colleges for forensic science, which offer specialized courses that integrate chemistry principles with investigative techniques.

Advancing your education through an online master's in forensic psychology can complement a chemistry background by providing insights into criminal behavior and legal processes. This multidisciplinary approach enhances career prospects in forensic analysis and consultation roles.

When considering career options, understanding the earning potential is important. According to recent data on forensic scientist salary, individuals with degrees in chemistry-related forensic fields can expect competitive compensation that grows with experience and specialized skills.

Cost is another critical factor for many students. Evaluating tuition and fees through resources like criminal justice degree cost helps prospective students select programs that fit their budget while ensuring quality education and career readiness.

Best Scientists Citing Lloyd R. Kelland

Recently Published Articles